News H2 Global Group – Approval of the First SÚKL Clinical Trial for Molecular Hydrogen Inhalation H2 Global Group – Approval of the First SÚKL Clinical Trial for Molecular Hydrogen Inhalation 26. 01. 2026 Share Tweet Pin It